Table 1.
Action | Mechanism(s) |
---|---|
Cytosolic enzyme inhibition | Oxidation, nitration |
Membrane pump inhibition | Oxidation, nitration |
Antioxidant enzyme inhibition | Oxidation, nitration |
Signal transduction pathway disturbances | Oxidation, nitration |
DNA injury | Oxidation, nitration, deamination, adduct formation |
Surfactant protein damage | Nitration |
Metalloproteinase activation | S-glutoxidation of prometalloproteinases |
Antioxidant enzyme depletion | Glutathione, cysteine oxidation |
Inhibition of BH4-dependent enzymes | Direct BH4 oxidation |
Inhibition of NAD-dependent enzymes | NAD oxidation, NAD depletion via PARP |
Lipid peroxidation | Peroxidation |
Oxidative chain reactions | Lipid peroxidation, generation of reactive alpha-oxoaldehydes from glucose |
Mitochondrial dysfunction | Inhibition of cytochromes, NADH-COQ1, etc. |
Upregulation of adhesion receptors | NF- κB activation |
GAPDH inhibition | Multiple, including PARP activation |
Protein kinase C activation | Multiple, including GAPDH inhibition via PARP activation |
Active DNA fragmentation | Caspase activation |
Calcium dysregulation | Dysfunctional calcium pumps and cell energetics |
Cell Necrosis | Mitochondrial injury, energetic collapse, oxidation, nitration, antioxidant depletion, calcium dysregulation |
Apoptosis | Mitochondrial injury, DNA injury, caspase activation, signal transduction disturbances, calcium dysregulation |
(Please note that to date many of the mechanisms listed have been demonstrated in vitro but not in experimental or clinical diabetes in vivo).